25,468 Shares in HealthEquity, Inc. (NASDAQ:HQY) Bought by Congress Asset Management Co.

Congress Asset Management Co. purchased a new stake in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm purchased 25,468 shares of the company's stock, valued at approximately $2,444,000.

A number of other large investors have also recently modified their holdings of HQY. UMB Bank n.a. boosted its position in shares of HealthEquity by 65.6% during the 4th quarter. UMB Bank n.a. now owns 414 shares of the company's stock valued at $40,000 after acquiring an additional 164 shares during the last quarter. Quarry LP boosted its position in shares of HealthEquity by 418.8% during the 3rd quarter. Quarry LP now owns 1,349 shares of the company's stock valued at $110,000 after acquiring an additional 1,089 shares during the last quarter. 1620 Investment Advisors Inc. bought a new stake in shares of HealthEquity during the 3rd quarter valued at about $112,000. GAMMA Investing LLC boosted its position in shares of HealthEquity by 32.9% during the 4th quarter. GAMMA Investing LLC now owns 1,248 shares of the company's stock valued at $120,000 after acquiring an additional 309 shares during the last quarter. Finally, Covestor Ltd lifted its position in HealthEquity by 27.4% in the 3rd quarter. Covestor Ltd now owns 1,524 shares of the company's stock worth $125,000 after buying an additional 328 shares during the last quarter. Institutional investors own 99.55% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on HQY. Barrington Research boosted their target price on HealthEquity from $105.00 to $120.00 and gave the stock an "outperform" rating in a research report on Monday, December 2nd. JMP Securities boosted their target price on HealthEquity from $105.00 to $107.00 and gave the stock a "market outperform" rating in a research report on Tuesday, December 10th. BTIG Research boosted their target price on HealthEquity from $110.00 to $130.00 and gave the stock a "buy" rating in a research report on Thursday, November 14th. Bank of America boosted their target price on HealthEquity from $100.00 to $120.00 and gave the stock a "buy" rating in a research report on Wednesday, November 13th. Finally, Royal Bank of Canada boosted their target price on HealthEquity from $100.00 to $105.00 and gave the stock an "outperform" rating in a research report on Tuesday, December 10th. One equities research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $110.71.

Insider Activity

In related news, Director Stuart B. Parker sold 25,000 shares of the company's stock in a transaction on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total value of $2,418,000.00. Following the sale, the director now directly owns 19,061 shares of the company's stock, valued at $1,843,579.92. This represents a 56.74 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Robert W. Selander sold 5,750 shares of the company's stock in a transaction on Monday, February 10th. The stock was sold at an average price of $111.29, for a total value of $639,917.50. Following the completion of the sale, the director now directly owns 78,219 shares in the company, valued at approximately $8,704,992.51. The trade was a 6.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 39,000 shares of company stock valued at $3,895,788. Company insiders own 2.20% of the company's stock.

HealthEquity Trading Down 2.8 %

HQY stock traded down $3.12 during midday trading on Friday, hitting $108.60. The company had a trading volume of 587,767 shares, compared to its average volume of 731,005. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. HealthEquity, Inc. has a 52 week low of $65.01 and a 52 week high of $115.59. The stock has a market cap of $9.41 billion, a price-to-earnings ratio of 99.63, a PEG ratio of 1.63 and a beta of 0.55. The stock's 50 day moving average price is $103.66 and its 200 day moving average price is $92.05.

HealthEquity (NASDAQ:HQY - Get Free Report) last posted its earnings results on Monday, December 9th. The company reported $0.59 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same period in the previous year, the firm earned $0.40 EPS. As a group, equities research analysts expect that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.